Core Viewpoint - PDRN is expected to be a popular skincare ingredient by 2026, with a projected CAGR of 49% in the Chinese market from 2023 to 2029, indicating rapid growth in demand for related products [2][5]. Group 1: PDRN Research and Development - The UNISKIN MED center has been providing various PDRN/PN treatments since 2020, accumulating nearly 6 years of clinical experience with over 10,000 cases [7]. - UNISKIN has developed a dual approach in functional skincare and professional medical aesthetics, enhancing its exploration in the PDRN research field [9]. - The company has introduced a PDRN skincare and medical treatment model, showing significant efficacy in various applications such as scar treatment and anti-aging [11]. Group 2: Scientific Standards and Regulations - UNISKIN, in collaboration with the Chinese Society of Plastic Surgery, launched the "PDRN/PN Cosmetics Application Specification" to standardize the quality and safety of PDRN/PN ingredients in skincare products [23]. - The specification addresses three major challenges in the PDRN sector: defining molecular weight, standardizing application amounts, and establishing detection methods for PDRN in cosmetics [24][27]. - The recommended addition of PDRN/PN raw materials is between 0.0001% and 1%, depending on specific conditions [25]. Group 3: Molecular Weight Control and Mechanisms - UNISKIN has developed the NeoEdge sequence cutting technology to precisely control PDRN molecular weight, creating the PDRN-850K core ingredient that activates five anti-aging pathways [16][19]. - The precise control of molecular weight is crucial for effective transdermal delivery and achieving the desired effects, addressing challenges such as low penetration efficiency and unclear mechanisms [14][20]. - The company emphasizes that effective PDRN application requires understanding the skin environment and controlling inflammation before activating systemic anti-aging pathways [13][19]. Group 4: Industry Position and Future Directions - UNISKIN's commitment to deep scientific research positions it as a leader in the PDRN market, providing a clear path for high-quality development in the industry [21][42]. - The establishment of industry standards signifies a maturation of the PDRN sector, allowing for more informed consumer choices and reducing the risks associated with unregulated growth [29][31]. - UNISKIN's innovative approach and rigorous research standards are expected to drive further exploration of PDRN's potential in skincare, highlighting the need for a more professional perspective in the industry [40][42].

Core Viewpoint - The PDRN skincare market is experiencing rapid growth, prompting the industry to consider its future direction and potential applications more thoughtfully [2][4][28]. Group 1: Market Position and Growth - Zhanmiya has been recognized as the leading brand in China's PDRN skincare market, receiving certification from Frost & Sullivan for having the highest sales in this segment [6][7]. - The market for PDRN products is projected to reach $289 million by 2025, with a significant increase in the number of registered PDRN products from over 1,700 in 2022 to 17,000 in the first half of this year [28][30]. - Zhanmiya's products have shown strong performance in both online and offline channels, achieving high order and repurchase rates, particularly during major sales events like Double Eleven [7][8]. Group 2: Product Innovation and Technology - Zhanmiya has developed proprietary technologies such as "球PDRN™" to enhance the transdermal absorption of PDRN, addressing previous technical challenges in the application of this ingredient [8][12]. - The newly launched 球PDRN™超能水光面膜 incorporates patented components that target mitochondrial repair and collagen synthesis, demonstrating significant efficacy in improving skin hydration and reducing signs of aging [17][19]. - The product's performance metrics include a 197.62% increase in ATP production efficiency and a 31.35% increase in type I collagen expression, showcasing its advanced formulation [17][19]. Group 3: Industry Standards and Compliance - The lack of standardized regulations in the PDRN skincare sector has raised concerns about product efficacy and safety, highlighting the need for clear guidelines [30][34]. - Zhanmiya and its parent company, Baihong Group, are actively involved in establishing industry standards, including the recently released guidelines for PDRN raw material testing [31][33]. - The establishment of these standards aims to ensure high-quality applications of PDRN, providing a framework for brands to measure effectiveness and maintain compliance, thus fostering a healthier market environment [34][35].